LifeMD
LFMD
114 hedge funds and large institutions have $139M invested in LifeMD in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 39 closing their positions.
38% more call options, than puts
Call options by funds: $5.22M | Put options by funds: $3.79M
9.52% less ownership
Funds ownership: 52.69% → 43.17% (-9.5%)
11% less funds holding
Funds holding: 128 → 114 (-14)
20% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 41
36% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 39
57% less capital invested
Capital invested by funds: $326M → $139M (-$187M)
Top Buyers
Top Sellers
LFMD Hedge Fund Activity: Q3 2025 in Review
114 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q3 2025, worth a combined $139M — down 57% from $326M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of LFMD and 25 opened new positions — a net loss of 14 holders — while 41 trimmed existing stakes and 33 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.43M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), exiting entirely with an estimated $12.6M sold.
- 114 institutional investors held LifeMD (LFMD) as of Q3 2025, down from 128 in Q2 2025.
- Funds reported $139M of LifeMD stock for Q3 2025, down 57% quarter-over-quarter.
- 25 funds opened new LifeMD positions in Q3 2025 and 39 closed out, a net change of -14 holders.
- The largest LifeMD buyer in Q3 2025 was Citadel Advisors, an estimated $5.43M added.
- The largest LifeMD seller in Q3 2025 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $12.6M sold.
Based on aggregated 13F filings for Q3 2025.